Back to results
US 2018/0000809 A1Published application
Use of bgp15 to treat familial dysautonomia
AssigneesMontana State University, N-Gene Research Laboratories, Inc.
InventorsFrances Brenda LEFCORT, Michael Jay BROWNSTEIN
Life of this patent
Estimating the term…
Abstract
Disclosed is the use of O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime (BGP15), its tautomers, enantiomers and pharmaceutically acceptable salts thereof for the treatment of Familial Dysaustonomia.
Claims1
A method of treating familial dysautonomia in a subject, such method comprising administering to such subject an effective amount of the compound of formula I
- tautomers, enantiomers, or pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.